CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 195 filers reported holding CLOVIS ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $207,000 | -46.5% | 13,942 | -10.5% | 0.01% | -47.4% |
| Q1 2019 | $387,000 | +38.7% | 15,582 | +0.4% | 0.02% | +11.8% |
| Q4 2018 | $279,000 | -51.3% | 15,522 | -20.4% | 0.02% | -22.7% |
| Q3 2018 | $573,000 | -29.3% | 19,496 | +9.5% | 0.02% | -31.2% |
| Q2 2018 | $810,000 | -12.7% | 17,804 | +1.3% | 0.03% | -13.5% |
| Q1 2018 | $928,000 | -29.2% | 17,577 | -8.8% | 0.04% | -26.0% |
| Q4 2017 | $1,310,000 | -25.3% | 19,263 | -9.5% | 0.05% | -31.5% |
| Q3 2017 | $1,753,000 | +564.0% | 21,278 | +10.7% | 0.07% | +461.5% |
| Q2 2016 | $264,000 | -30.3% | 19,227 | -2.5% | 0.01% | -35.0% |
| Q1 2016 | $379,000 | -55.6% | 19,729 | -19.0% | 0.02% | -50.0% |
| Q4 2015 | $853,000 | -61.5% | 24,359 | +1.1% | 0.04% | -68.3% |
| Q3 2015 | $2,217,000 | – | 24,105 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
| Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
| ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
| Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
| Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
| Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
| WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
| PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
| Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
| Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |